A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

NCT00976391 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

586

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

BIOLOGICAL: albiglutide + insulin glargine
DRUG: insulin glargine + preprandial lispro insulin

Sponsor

GlaxoSmithKline